INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 49m ago
House PTR9m ago
SEC 13F8m ago
Robinhood Chain8m ago

Results

26,449 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
30
GM
Gloria MelanieChief Operating Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$217K
8,722 sh
Apr 8, 2026Apr 10, 2026
Page 434 of 662
← PrevNext →
traded Apr 8, 2026
+2d
SEC Form 4

Evidence

30
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$84K
13.1K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

29
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$727K
8,080 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

29
LT
Li TianminChief Technology Officer
VIPSVipshop Holdings Ltd
Open-market sale
SELL$193K
2,482 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

29
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$654K
7,270 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

28
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$143K
10.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

28
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$141K
10.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

28
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$143K
10.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

28
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$72K
5,000 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

28
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$143K
10.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

28
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$69K
4,760 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

28
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$144K
10.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

28
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$75K
5,240 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

28
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$143K
10.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

28
NM
Neagle MatthewChief Operating Officer
PRCHPorch Group, Inc.
Open-market sale
SELL$449K
62.8K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

27
SS
Stout Jay SChief Technology Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$38K
1,518 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

27
GJ
Gold JudithDirector
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
1,714 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$219K
2,400 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

26
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$340K
22.6K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$237K
2,600 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$55K
600 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
700 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

25
MM
Mindlin Damian MiguelVice President
PAMPampa Energy Inc.
Open-market sale
SELL$200K
57.5K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

23
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$9,340
100 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

23
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$9,340
100 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

23
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1,288
14 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

22
BC
Billingsley ChesterDirector, Chief Executive Officer, 10% Owner
MNTRMentor Capital, Inc.
Open-market purchase
BUY$65.1
1,050 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

22
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$49K
14.5K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

22
BC
Billingsley ChesterDirector, Chief Executive Officer, 10% Owner
MNTRMentor Capital, Inc.
Open-market purchase
BUY$57
950 sh
Apr 10, 2026Apr 10, 2026
traded Apr 10, 2026
+0dSEC Form 4

Evidence

22
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
1,683 sh
Apr 7, 2026Apr 10, 2026
traded Apr 7, 2026
+3dSEC Form 4

Evidence

22
TS
Tabak ShawnCHIEF FINANCIAL OFFICER
PRCHPorch Group, Inc.
Open-market sale
SELL$55K
7,734 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

22
BC
Billingsley ChesterDirector, Chief Executive Officer, 10% Owner
MNTRMentor Capital, Inc.
Open-market purchase
BUY$124
2,000 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

19
RS
Robins Harlan SChief Scientific Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$149K
10.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

18
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.13M
1,956 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

18
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.02M
1,756 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

17
MJ
McCallion Kevin J.SVP, Products and Production
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$131K
18.6K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$9,152
1,931 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$14K
2,800 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
3,310 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$1,978
162 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence